Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer have?
Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer has 6,696 citations in the OpenAlex counts ScholarIQ stores.
When was Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer published?
Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer has 2018 year in the ScholarIQ index.
What is the open-access status of Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer?
Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer has bronze oa status in the ScholarIQ index.
What is the DOI of Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer?
The DOI for Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer is on the source record.
What is the PMID of Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer?
The PMID for Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer is on the source record.
What is the OpenAlex record for Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer?
The OpenAlex for Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer is on the source record.